European Parliament Signs Off Regulation To Tackle Medicine Shortages
Executive Summary
The legislation will establish a new EU platform for monitoring and reporting medicines shortages.
You may also be interested in...
What’s Next? Five Things To Look Out For In March
This month, generic competition to several lucrative brands, not least Bristol Myers Squibb’s $8.7bn Revlimid, are set to fall to generic competition in the US. Meanwhile, Sawai is looking to close on a key deal.
New EU Bodies To Monitor Drug Supply In Health Crises
New pandemic-related responsibilities have been entrusted to the European Medicines Agency by a regulation published on 31 January. They include coordinating vaccine safety and effectiveness studies and setting up a European network of real-world data to help support health crisis preparedness and response.
EU Bodies Agree On New Drug Shortage Monitoring Platform
Two EU institutions have reached a deal on legislation that will give the EMA a key tool for monitoring medicines supply and preventing shortages in the event of a major public health crisis such as a future pandemic.